Kangstem Biotech ranked among the top searched stocks on three days within the past month.


As of 12:30 PM on the 13th, Kangstem Biotech is trading at 8,720 KRW, up 1.4% from the previous day. This marks a 31.72% increase compared to September 24. Kangstem Biotech is known as a developer, manufacturer, and supplier of stem cell therapies.

Over the past five days, individual investors have net purchased 979,272 shares, while foreigners and institutions have net sold 20,555 shares and 952,969 shares, respectively.


On October 12, Kangstem Biotech became a market topic with the news of "successful reconstruction of transplantable artificial liver," leading to a price increase.



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing